We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Hyatt to Set Foot in Scotland, Expand Hyatt Regency Brand
Read MoreHide Full Article
Hyatt Hotels Corporation (H - Free Report) recently signed an agreement to open a luxury hotel in Edinburgh, Scotland. The property will be Hyatt’s first hotel in Scotland and third Hyatt Regency property in the United Kingdom. The hotel, comprising 187 guest rooms and 98 apartments, is expected to open in 2021.
The move underscores Hyatt’s efforts to expand and strengthen its brand name. Meanwhile, shares of Hyatt have declined 0.3% in the past year, outperforming the industry’s decline of 15.2%.
Expansion Strategies on Track
Hyatt’s continuous efforts toward expanding brands globally help to expand market share in the hospitality industry, thereby boosting business operations. This enhances its portfolio and prospects in terms of revenue and profitability. Hyatt’s aim to differentiate its brands from one another by providing distinct travel experiences lends it a competitive edge.
In fact, Hyatt has expansion plans in diverse international markets, including Australia, Brazil, Germany, Indonesia and others. Markedly, the company’s new signings across its brands globally have consistently outpaced its openings and this trend is expected to continue in 2018.
Notably, Hyatt registered net room growth of 7.6% on a year-over-year basis in third-quarter 2018, which marked the 14th successive quarter of growth above 6%. The company’s development pipeline grew roughly 6% in the quarter from a year ago. For 2018, it expects to grow units on a net room basis by 6.5-7%, reflecting 60 hotel openings.
Our Take
We believe that the recent hotel addition will strengthen the Hyatt Regency brand’s global footprint and boost Hyatt’s Owned and Leased Hotels revenues. In the third quarter of 2018, revenues from Owned and Leased Hotels were $443 million, down 13.3% (12.9% on a constant currency) from the year-ago figure. Adjusted EBITDA of the segment also decreased 12.5% to $91 million.
Belmond has an expected current-year earnings growth rate of 150%.
DISH Network has an expected current-year earnings growth rate of 14.6%.
Rogers Communications has an expected current-year earnings growth rate of 19.6%.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
Image: Bigstock
Hyatt to Set Foot in Scotland, Expand Hyatt Regency Brand
Hyatt Hotels Corporation (H - Free Report) recently signed an agreement to open a luxury hotel in Edinburgh, Scotland. The property will be Hyatt’s first hotel in Scotland and third Hyatt Regency property in the United Kingdom. The hotel, comprising 187 guest rooms and 98 apartments, is expected to open in 2021.
The move underscores Hyatt’s efforts to expand and strengthen its brand name. Meanwhile, shares of Hyatt have declined 0.3% in the past year, outperforming the industry’s decline of 15.2%.
Expansion Strategies on Track
Hyatt’s continuous efforts toward expanding brands globally help to expand market share in the hospitality industry, thereby boosting business operations. This enhances its portfolio and prospects in terms of revenue and profitability. Hyatt’s aim to differentiate its brands from one another by providing distinct travel experiences lends it a competitive edge.
In fact, Hyatt has expansion plans in diverse international markets, including Australia, Brazil, Germany, Indonesia and others. Markedly, the company’s new signings across its brands globally have consistently outpaced its openings and this trend is expected to continue in 2018.
Notably, Hyatt registered net room growth of 7.6% on a year-over-year basis in third-quarter 2018, which marked the 14th successive quarter of growth above 6%. The company’s development pipeline grew roughly 6% in the quarter from a year ago. For 2018, it expects to grow units on a net room basis by 6.5-7%, reflecting 60 hotel openings.
Our Take
We believe that the recent hotel addition will strengthen the Hyatt Regency brand’s global footprint and boost Hyatt’s Owned and Leased Hotels revenues. In the third quarter of 2018, revenues from Owned and Leased Hotels were $443 million, down 13.3% (12.9% on a constant currency) from the year-ago figure. Adjusted EBITDA of the segment also decreased 12.5% to $91 million.
Zacks Rank & Stocks to Consider
Hyatt carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Consumer-Discretionary sector are Belmond Ltd. , DISH Network Corporation and Rogers Communications Inc. (RCI - Free Report) . While Belmond carries a Zacks Rank #1 (Strong Buy), DISH Network and Rogers Communications carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Belmond has an expected current-year earnings growth rate of 150%.
DISH Network has an expected current-year earnings growth rate of 14.6%.
Rogers Communications has an expected current-year earnings growth rate of 19.6%.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
See them today for free >>